REGENXBIO Inc. Form 8-K Summary
Business Context and Reporting Period
REGENXBIO Inc. filed this Current Report on Form 8-K on January 3, 2019. The filing serves to incorporate by reference a press release detailing the Company's operational highlights and financial condition for the fiscal year ended December 31, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release filed as Exhibit 99.1, which is referenced but not reproduced in the body of this 8-K. The filing explicitly notes that disclosures regarding cash, cash equivalents, and marketable securities as of December 31, 2018, are furnished in Exhibit 99.1.
Material Changes
The filing does not detail specific material changes versus the prior comparable period within the text provided. It directs readers to the press release (Exhibit 99.1) for operational highlights and financial condition updates for the year ended December 31, 2018.
Guidance, Outlook, and Risks
The press release incorporated by reference includes anticipated milestones and financial guidance for the year ending December 31, 2019. The filing explicitly states that the information regarding financial guidance and cash positions is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 3, 2019) for specific cash, cash equivalents, and marketable securities balances as of December 31, 2018.
- Examine Exhibit 99.1 for detailed financial guidance and anticipated milestones for the 2019 fiscal year.
- Verify operational highlights for the 2018 fiscal year in the referenced press release, as they are not detailed in the 8-K text.
- Note the legal distinction that financial guidance and cash position data in this filing are "furnished" rather than "filed," affecting liability under Section 18 of the Exchange Act.